Lincocin

País: Nova Zelândia

Língua: inglês

Origem: Medsafe (Medicines Safety Authority)

Ingredientes ativos:

Lincomycin hydrochloride monohydrate equivalent to 250 mg lincomycin base;  

Disponível em:

Pharmacia Limited Company trading as Pharmacia

DCI (Denominação Comum Internacional):

Lincomycin hydrochloride monohydrate (=250 mg lincomycin base)

Dosagem:

250 mg

Forma farmacêutica:

Capsule

Composição:

Active: Lincomycin hydrochloride monohydrate equivalent to 250 mg lincomycin base   Excipient: Lactose monohydrate Magnesium stearate Purified talc

Unidades em pacote:

Bottle, plastic, 1x24, 24 capsules

Classe:

Prescription

Tipo de prescrição:

Prescription

Fabricado por:

Pfizer Pharmaceuticals LLC

Indicações terapêuticas:

indicated in the treatment of upper respiratory infections including tonsillitis, pharyngitis, otitis media, sinusitis, scarlet fever and as adjuvant therapy for diphtheria. Effectiveness in the treatment of mastoiditis would be anticipated.

Resumo do produto:

Package - Contents - Shelf Life: Bottle, plastic, - 24 capsules - 60 months from date of manufacture stored at or below 25°C - Bottle, plastic, - 100 capsules - 60 months from date of manufacture stored at or below 25°C

Data de autorização:

1969-12-31